1.Recognition of the Y chromosome in Turner syndrome using peripheral blood or oral mucosa tissue
Lene Garcia BARBOSA ; Adriana Aparecida SIVIERO-MIACHON ; Maria Anunciação SOUZA ; Angela Maria SPINOLA-CASTRO
Annals of Pediatric Endocrinology & Metabolism 2021;26(4):272-277
Purpose:
Turner syndrome is defined as total or partial loss of the second sex chromosome in a phenotypically female patient. Due to the possibility of hidden mosaicism of fragments of the Y chromosome and development of gonadoblastoma, we evaluated the presence of such fragments in 2 tissues with different embryonic origins, peripheral blood lymphocytes (mesoderm), and oral mucosal cells (ectoderm) using multiplex polymerase chain reaction.
Methods:
DNA samples were collected from 109 patients, and primers for the SRY, TSPY, and AMELX genes were used.
Results:
We found 14 patients (12.8%) with positive molecular markers for the Y chromosome. The study of tissues of different embryological origin showed the same degree of agreement, sensitivity, and specificity.
Conclusion
Oral mucosa cells have a simpler method of collection that is less invasive and requires less time for DNA extraction at a lower cost.
2.Adipokines in young survivors of childhood acute lymphocytic leukemia revisited: beyond fat mass
Adriana Aparecida SIVIERO-MIACHON ; Angela Maria SPINOLA-CASTRO ; Solange ANDREONI ; Maria Lucia de Martino LEE ; Antonio Ramos CALIXTO ; Bruno GELONEZE ; Gil GUERRA-JUNIOR
Annals of Pediatric Endocrinology & Metabolism 2020;25(3):174-181
Purpose:
This cross-sectional study evaluated the relationship between adipokines (leptin, adiponectin, visfatin, and resistin) and adiposity indexes regarding sex and cranial radiotherapy exposure among young acute lymphocytic leukemia survivors.
Methods:
A multivariate analysis of covariance (MANCOVA) was used to evaluate the joint effect of sex, cranial radiotherapy, and body mass index (BMI) z-score (model 1) or fat mass index (FMI) (model 2) on adipokines.
Results:
This study included 55 survivors of childhood acute lymphocytic leukemia between 15 and 23 years of age from both sexes (56.4% female); 43.6% of the sample had undergone cranial radiotherapy (18–24 Gy). The BMI z-score, the FMI, and sex (P<0.050 for all) influenced at least one adipokine, while cranial radiotherapy exposure was marginal in model 2. Parameter estimates from the MANCOVA's final model showed that the BMI z-score (β=-0.437, P=0.010) and the FMI (β=-0.209, P=0.004) negatively influenced adiponectin, while the FMI positively affected resistin (β=0.142, P=0.020). The relationship between leptin, visfatin, and the adiposity ndexes could not be established. In model 1, females presented with increased adiponectin (β=-1.014, P=0.011) and resistin (β=-1.067, P=0.002) levels; in model 2, female sex positively affected adiponectin (β=-1.515, P=0.001) and marginally influenced resistin (β=-0.707, P=0.054) levels. Cranial radiotherapy negatively determined visfatin levels in both final models (P<0.050).
Conclusion
Changes in body fat may be associated with adipose tissue dysfunction and should be carefully evaluated in survivors of acute lymphocytic leukemia, considering both sex and cranial radiotherapy exposure, to treat disorders that may possibly aggravate their risk for early cardiovascular disease.